Handelsbanken Fonder’s Ascendis Pharma A/S ASND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.21M	Buy	27,050 +11,583	+75%	+$2.71M	0.02%	427
2026 Q1	$3.54M	Buy	15,467 +1,200	+8%	+$269K	0.01%	561
2025 Q4	$3.04M	Buy	14,267 +700	+5%	+$145K	0.01%	609
2025 Q3	$2.7M	Buy	13,567 +1,300	+11%	+$242K	0.01%	634
2025 Q2	$2.12M	Buy	12,267 +700	+6%	+$114K	0.01%	638
2025 Q1	$1.8M	Sell	11,567 -2,100	-15%	-$300K	0.01%	690
2024 Q4	$1.88M	Sell	13,667 -4,000	-23%	-$526K	0.01%	697
2024 Q3	$2.64M	Buy	17,667 +4,200	+31%	+$567K	0.01%	575
2024 Q2	$1.84M	Buy	13,467 +1,200	+10%	+$163K	0.01%	611
2024 Q1	$1.85M	Buy	12,267 +900	+8%	+$128K	0.01%	626
2023 Q4	$1.43M	Hold	11,367	–	–	0.01%	659
2023 Q3	$1.06M	Buy	11,367 +2,367	+26%	+$221K	0.01%	701
2023 Q2	$803K	Buy	9,000 +500	+6%	+$43.5K	﹤0.01%	829
2023 Q1	$911K	Buy	8,500 +1,400	+20%	+$160K	0.01%	732
2022 Q4	$867K	Sell	7,100 -2,500	-26%	-$290K	0.01%	703
2022 Q3	$991K	Hold	9,600	–	–	0.01%	662
2022 Q2	$892K	Sell	9,600 -100	-1%	-$9.43K	0.01%	733
2022 Q1	$1.14M	Hold	9,700	–	–	0.01%	742
2021 Q4	$1.3M	Sell	9,700 -900	-8%	-$134K	0.01%	774
2021 Q3	$1.69M	Buy	10,600 +1,300	+14%	+$178K	0.01%	673
2021 Q2	$1.22M	Hold	9,300	–	–	0.01%	812
2021 Q1	$1.2M	Sell	9,300 -1,000	-10%	-$152K	0.01%	763
2020 Q4	$1.72M	Buy	10,300 +1,600	+18%	+$265K	0.01%	637
2020 Q3	$1.34M	Hold	8,700	–	–	0.01%	634
2020 Q2	$1.29M	Buy	+8,700	New	+$1.19M	0.01%	618

Other funds holding ASND